Billionaire Paul Tudor Jones’ Top Picks Include Automatic Data Processing Inc. (ADP), NCR Corporation (NCR)

Paul Tudor Jones’ hedge fund also increased its stake in Pfizer Inc. (NYSE:PFE) by 753,085 shares to 1.14 million shares valued at $39.61 million. Despite the fact that the stock has increased by slightly more than 10% since the beginning of 2015, it still has more room to run as the company is stipulated to make new acquisitions that would assist in maintaining its growth levels. Recently, the company announced the acquisition of Hospira Inc. (NYSE:HSP) for $17 billion, which will help them enhance the future profit and sales figures as well as increase the savings from resulting synergies. Moreover, analysts have been speculating that Pfizer is looking for new targets even though the company is still in the process of acquiring Hospira. Meanwhile, Kahn Brothers, co-founded by the late Irving Kahn, is one of the many hedge funds that still remain bullish on Pfizer Inc. (NYSE:PFE).

The latest 13F filing also reveals that Tudor Investment Corporation has initiated a long position in Visa Inc. (NYSE:V) during the January-March period. The hedge fund acquired 534,640 shares worth $34.97 million. Just recently, Visa, which is one of FIFA’s biggest sponsors, declared that the company intends to withdraw its funding and put an end to its agreement with FIFA as the soccer organization’s recent corruption scandal spurred. Thus, Visa’s announcement may result in increased brand image as the message surely conveys the fact that this company fights fearlessly against all forms of injustice and corruption. Visa’s stock is up by more than 6% in 2015 and the recent corruption scandal at FIFA did not hurt the stock at all as it seized a strong uptrend lately. Ken Fisher’s Fisher Asset Management, currently the largest shareholder of Visa Inc. (NYSE: V) among the funds we track, increased its already substantial holding to 14.32 million shares held as of the end of March.

Disclosure: None